| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.001 |